Status:
COMPLETED
The Effect of Inulin Supplementation in Individuals With IBS-C
Lead Sponsor:
Mardin Artuklu University
Conditions:
Inulin
IBS (Irritable Bowel Syndrome)
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
Background: This study aimed to evaluate the effects of inulin supplementation on nutritional intake, anthropometric parameters, and bowel symptoms in individuals diagnosed with IBS-C. Method: This w...
Detailed Description
Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder characterised by chronic abdominal pain, bloating, and altered bowel habits, often without identifiable organic patholog...
Eligibility Criteria
Inclusion
- the individuals were between 19-65 years of age
- volunteer to participate in the study
- Individuals diagnosed with IBS by a physician according to Rome IV criteria
Exclusion
- a history of gastrointestinal surgery (except appendectomy and cholecystectomy)
- inflammatory bowel disease
- lactose malabsorption
- gastroenteritis
- celiac disease
- gastric
- duodenal ulcer
- metabolic diseases (cardiac, hepatic and renal diseases, diabetes, etc.)
- history of malignancy
- pregnancy and lactation
- use of intestinal motility
- antidepressant drugs
- involuntary body weight loss of more than 5 kg in the last 3 months
- use of dietary fibre supplements in the last 3 months
- use of antibiotics in the last 3 months
- use of prebiotic and probiotic supplements in the last 3 months.
Key Trial Info
Start Date :
November 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06945302
Start Date
November 3 2021
End Date
April 1 2023
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mardin Artuklu University
Mardin, Turkey (Türkiye), 47200